JUBILANT.NS - Jubilant Life Sciences Limited

NSE - NSE Real Time Price. Currency in INR
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue3/31/20183/31/20173/31/20163/31/2015
Total Revenue75,178,40058,614,33057,491,33058,262,470
Cost of Revenue32,936,80019,994,97021,174,77026,617,070
Gross Profit42,241,60038,619,36036,316,56031,645,400
Operating Expenses
Research Development----
Selling General and Administrative15,558,80012,799,48011,673,57011,284,120
Non Recurring----
Others11,499,00012,180,70011,755,67013,457,490
Total Operating Expenses63,234,90047,881,54048,071,45054,238,220
Operating Income or Loss11,943,50010,732,7909,419,8804,024,250
Income from Continuing Operations
Total Other Income/Expenses Net-3,352,700-3,356,370-3,997,650-3,621,010
Earnings Before Interest and Taxes11,943,50010,732,7909,419,8804,024,250
Interest Expense-2,842,800-3,008,370-3,351,750-3,269,680
Income Before Tax8,590,8007,376,4205,422,230403,240
Income Tax Expense2,246,6001,630,1601,554,000804,840
Minority Interest-515,200-392,880-381,330-381,330
Net Income From Continuing Ops6,344,2005,746,2603,868,230-401,600
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income6,428,1005,756,5303,918,310-577,640
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares6,428,1005,756,5303,918,310-577,640